10-Q – Page 215 – China Stock Advice

NFEC [NF Energyvingrp] 10-Q: (Original Filing)

[FORM 10-Q x for the Quarterly Period Ended September 30, 2009 o for the Transition Period from _______ to _______ NF Energyvingrporation Delaware 02-0563302 (State or Other Jurisdiction oforporation or organization) (I.R.S. Employer Identification No.) 21-Jia Bei Si Dong Road, Tie Xi Qu Shenyang, P. R. China 110021] [Certifications I, Gang, Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certifications I, Li Hua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the nine months ended September 30, 2009. NF Energyvingrporation Gang Li ( v166194_ex32-1.htm 4 EX-32.1] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the nine months ended September 30, 2009. NF Energyvingrporation Principal Financial and Accounting Officer) ( v166194_ex32-2.htm]

By info| 2016-02-08T09:21:43+00:00 November 13th, 2009|Categories: Chinese Stocks, NFEC, SEC Original|Tags: 0001213660, 10-Q, 2009-11-13, 3490, MISCELLANEOUS FABRICATED METAL PRODUCTS, NFEC|0 Comments

HPJ [Highpower International] 10-Q: (Original Filing)

[HONG KONG HIGHPOWER TECHNOLOGY, INC. FORM 10-Q For the Quarterly Period Ended September 30, 2009 INDEX Page Part I Financial Information Item 1. Financial Statements (a) Balance Sheets as of September 30, 2009 (Unaudited) and December 31, 2008 2] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Dang Yu Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Henry Ngan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dang Yu Pan Chairman of the Board and Chief Executive Officer November 12, 2009 Henry Ngan Chief Financial Officer (Principal Financial and Accounting Officer) November 12, 2009 EX-32.1 4 v165765_ex32-1.htm]

By info| 2016-03-14T11:54:41+00:00 November 12th, 2009|Categories: Chinese Stocks, HPJ, SEC Original|Tags: 0001368308, 10-Q, 2009-11-12, 3690, HPJ, MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT and SUPPLIES|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q x September 30, 2009 For the quarterly period ended o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from ______________ to _____________ 333-147363 BIOSTAR PHARMACEUTICALS, INC. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Road, Xianyang, Shaanxi Province, The People’s Republic] [I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc. (the "Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [I, Elaine Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc. (the "Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Elaine Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By info| 2016-03-03T15:34:54+00:00 November 12th, 2009|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2009-11-12, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

HPJ [Highpower International] 10-Q: HONG KONG HIGHPOWER TECHNOLOGY, INC. FORM 10-Q For

[HONG KONG HIGHPOWER TECHNOLOGY, INC. FORM 10-Q For the Quarterly Period Ended September 30, 2009 INDEX Page Part I Financial Information Item 1. Financial Statements (a) Balance Sheets as of September 30, 2009 (Unaudited) and December 31, 2008 2] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Dang Yu Pan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Henry Ngan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Hong Kong Highpower Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dang Yu Pan Chairman of the Board and Chief Executive Officer November 12, 2009 Henry Ngan Chief Financial Officer (Principal Financial and Accounting Officer) November 12, 2009 EX-32.1 4 v165765_ex32-1.htm]

By info| 2016-03-14T11:56:32+00:00 November 12th, 2009|Categories: Chinese Stocks, HPJ, Webplus ver|Tags: 0001368308, 10-Q, 2009-11-12, 3690, HPJ, MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT and SUPPLIES|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q x September 30, 2009 For the

[FORM 10-Q x September 30, 2009 For the quarterly period ended o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from ______________ to _____________ 333-147363 BIOSTAR PHARMACEUTICALS, INC. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Road, Xianyang, Shaanxi Province, The People’s Republic] [I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc. (the "Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [I, Elaine Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc. (the "Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. Elaine Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By info| 2016-03-03T15:35:58+00:00 November 12th, 2009|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2009-11-12, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q: (Original Filing)

[FORM 10-Q (Mark one) x For the quarterly period ended September 30, 2009 Or ¨ For the transition period from ________ to _________ China Automotive Systems, Inc. specified in its charter) Delaware 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) No. 1 Henglong Road, Yu Qiao Development Zone, Shashi District, Jing Zhou City, Hubei Province,] [CERTIFICATION I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu Chief Executive Officer EX-32.1 4 v165278_ex32-1.htm] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Chief Financial Officer EX-32.2 5 v165278_ex32-2.htm]

By info| 2016-03-28T19:08:39+00:00 November 12th, 2009|Categories: CAAS, Chinese Stocks, SEC Original|Tags: 0001157762, 10-Q, 2009-11-12, 3714, CAAS, MOTOR VEHICLE PARTS and ACCESSORIES|0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] 10-Q: FORM 10-Q (Mark one) x For the quarterly

[FORM 10-Q (Mark one) x For the quarterly period ended September 30, 2009 Or ¨ For the transition period from ________ to _________ China Automotive Systems, Inc. specified in its charter) Delaware 33-0885775 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) No. 1 Henglong Road, Yu Qiao Development Zone, Shashi District, Jing Zhou City, Hubei Province,] [CERTIFICATION I, Qizhou Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Jie Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Automotive Systems, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Qizhou Wu Chief Executive Officer EX-32.1 4 v165278_ex32-1.htm] [CHINA AUTOMOTIVE SYSTEMS, INC. 18 U.S.C. SECTION 1350, OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jie Li Chief Financial Officer EX-32.2 5 v165278_ex32-2.htm]

By info| 2016-03-28T19:10:08+00:00 November 12th, 2009|Categories: CAAS, Chinese Stocks, Webplus ver|Tags: 0001157762, 10-Q, 2009-11-12, 3714, CAAS, MOTOR VEHICLE PARTS and ACCESSORIES|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321093009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended September 30, 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322093009.htm]

By info| 2016-03-03T21:22:38+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2009-11-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q:

[] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321093009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended September 30, 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322093009.htm]

By info| 2016-03-03T21:24:52+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2009-11-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[China Pharmas, TABLE OFNTENTS Part I Financial Information 1 Item 1. Financial Statements 1ndensednsolidated Balance Sheets ofSeptember 30, 2009 and December 31, 2008 (Unaudited) 1ndensednsolidated Statements of Operations andmprehensiveome for the Three and Nine Months EndedSeptember 30, 2009 and 2008 (Unaudited)] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharmas, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharmas, certify that: 1)I have reviewed this quarterly report on Form 10-Q of China Pharmas,; 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the "Company") on Form 10-Q for the period ended September 30, 2009 filed with the Zhilin Li material respects, the financialndition and result of operations of thempany. Zhilin Li] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the for the period ended September 30, 2009 filed with the Frank Waung Chief Financial Officer cph10qex322093009.htm 5 EX-32.2]

By info| 2016-02-08T00:00:10+00:00 November 10th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2009-11-10, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments